MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:17556 chebi:17556 OFWYIUYVHYPQNX-JXFKEZNVSA-N | phaseollidin (-)-Phaseollidin (6aR,11aR)-10-(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol Phaseollidin |
lipidmaps:LMPK12070011 lipidmapsM:LMPK12070011 OFWYIUYVHYPQNX-JXFKEZNVSA-N | (-)-Phaseollidin |
metacyc.compound:CPD-4885 metacycM:CPD-4885 OFWYIUYVHYPQNX-JXFKEZNVSA-N | (-)-phaseollidin phaseollidin |
kegg.compound:C05230 keggC:C05230 OFWYIUYVHYPQNX-JXFKEZNVSA-N | Phaseollidin (-)-Phaseollidin |
seed.compound:cpd03103 seedM:cpd03103 OFWYIUYVHYPQNX-JXFKEZNVSA-N | Phaseollidin (-)-Phaseollidin (-)-phaseollidin phaseollidin |
vmhM:phsdln vmhmetabolite:phsdln OFWYIUYVHYPQNX-JXFKEZNVSA-N | Phaseollidin 15-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11(16),12,14-hexaene-5,14-diol |
chebi:14774 chebi:25948 chebi:8044 keggC:M_C05230 seedM:M_cpd03103 vmhM:M_phsdln | secondary/obsolete/fantasy identifier |